Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Killingley

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMJ Neurology Open|April 20, 2026
Prospective Evaluation of the Neurology Same Day Emergency Care (NeuroSDEC) Model in Secondary Care: data from 931 patients over the first 12 monthsAli Alim-Marvasti, Michelle Balaratnam, Benjamin Sacks, et al.
Plos Pathogens|July 14, 2020
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environmentJonathan S Nguyen-Van-Tam, Ben Killingley, Joanne Enstone, et al.
Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.
BMJ Open|June 24, 2021
Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort studyAndrew Hayward, Ellen Fragaszy, Jana Kovar, et al.
Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Nature|June 19, 2024
Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMJ Neurology Open|April 20, 2026
Prospective Evaluation of the Neurology Same Day Emergency Care (NeuroSDEC) Model in Secondary Care: data from 931 patients over the first 12 monthsAli Alim-Marvasti, Michelle Balaratnam, Benjamin Sacks, et al.
Plos Pathogens|July 14, 2020
Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environmentJonathan S Nguyen-Van-Tam, Ben Killingley, Joanne Enstone, et al.
Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.
BMJ Open|June 24, 2021
Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort studyAndrew Hayward, Ellen Fragaszy, Jana Kovar, et al.
Nature Communications|December 7, 2025
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infectionHelen R Wagstaffe, Ryan S Thwaites, Jasmin K Sidhu, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Nature Communications|November 30, 2024
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.
Nature|June 19, 2024
Human SARS-CoV-2 challenge uncovers local and systemic response dynamicsRik G H Lindeboom, Kaylee B Worlock, Lisa M Dratva, et al.
Pageof 2